ウェビナー動画：タンパク質エンジニアリングの複雑性への対応 - 二重／多重特異性抗体、TCR、CAR-T
Presented at PEGS Boston, Virtual Meeting
Amanda Fitzgerald, Ph.D., Senior Scientific Consultant, Genedata
We present a new technology platform to fully automate both molecular design, as well as the integrated assessment of potency, efficacy, and developability profiling of large panels of bispecific candidates. We will present use cases showing how the platform allows for the systematic cloning, expression, purification, and characterization of complex multi-specific, CAR T and TCR modalities, with a focus on immuno-oncology applications.